Overview

Study With Information Technology (IT) - Aided Preventive Program in Schizophrenia

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
Information Technology-aided Program of Relapse Prevention in Schizophrenia (ITAREPS) will decrease the number of hospitalizations in patients with schizophrenia or schizoaffective disorder who are treated in the outpatient psychiatric setting, as evidenced by the reduction of the total number of hospitalizations due to relapse of psychosis at the end of the 12-months follow-up period in the active ITAREPS group compared to the control (treatment-as-usual) group.
Phase:
N/A
Details
Lead Sponsor:
Prague Psychiatric Center
Collaborator:
Eli Lilly and Company
Treatments:
Antipsychotic Agents